SEC Comment Letter for AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Jul 29, 2019
AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: July 29, 2019 · CIK: 0001460702 · Accession: 0000000000-19-011704
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232798
Letter
July 29, 2019 Andrew J. Ritter Chief Executive Officer Ritter Pharmaceuticals, Inc. 1880 Century Park East #1000 Los Angeles, CA 90067 Re:Ritter Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed July 24, 2019 File No. 333-232798 Dear Mr. Ritter: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Julia Griffith at 202-551-3267 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
July 29, 2019
Andrew J. Ritter
Chief Executive Officer
Ritter Pharmaceuticals, Inc.
1880 Century Park East #1000
Los Angeles, CA 90067
Re:Ritter Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed July 24, 2019
File No. 333-232798
Dear Mr. Ritter:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Julia Griffith at 202-551-3267 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance